← Back to all signals
RESEARCH PAPER ANALYSIS

THE PROLIFERATIVE-DIFFERENTIAL PROCESSES IN BONE MARROW UNDER CHEMOTHERAPY DELIVERY DEPENDING ON THE IRON METABOLISM IN CHILDREN WITH ACUTE LYMPHOID LEUKEMIA LIVING IN RADIOLOGICALLY CONTAMINATED TERRITORIES.

AI interpretation is pending for this paper.

Open original publication →
PMID41469356
JournalProblemy radiatsiinoi medytsyny ta radiobiolohii
Publication Date2025-12-01
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: assessment of the role of iron metabolism in proliferation, differentiation and hematopoietic recoverytypes under the chemotherapy (CT) delivery in children with acute lymphoid leukemia (ALL), living in radiologically contaminated territories (RCT) of Ukraine. MATERIALS AND METHODS: The ALL patients (n = 61) aged 3 to 15 years, residing in RCT, were examined. The observation period was 20 years. There were preB (n = 7), «general» type (n = 50), and proB (n = 4) ALL variants amongthe study subjects. Patients had received CT according to the adapted protocols by the BerlinFrankfurtMunstergroup (BFM). Study schedule featured the Period «0» before the CT initiation with respective studied parameters,Period 1 and Period 2 corresponding to the remission induction therapy, and periods 3, 4 and 5 corresponding to theremission consolidation therapy. The hemogram and myelogram parameters were studied during all periods. Serumiron (SI), serum ferritin (SF) and transferrin levels were assayed. The results of treatment were taken into account.Radiation doses to the bone marrow (BM) were calculated. RESULTS: There was the highest BM cellularity by the number of myelokaryocytes (MKC) ((202.0 ± 21.2) G/l) beforeCT initiation due to the tumor clone followed by a decrease during periods of remission induction therapy andincrease during periods of consolidation ((126.7 ± 11.5) G/l), not exceeding however the limits of normative values.More often the BM recovery during CT had occurred by the granulocytic type. The erythroid type was observed in athird of patients only at the beginning of CT. The monocytic type was specific to the patients in the first periods ofconsolidation. After the end of CT the content of iron in 62.3 % of children was within normal range with in 37.7 %of them being increased ((38.0 ± 2.1) μmol/l). Level of iron in 24.6 % of patients was high ((345.3 ± 16.4) ng/ml),indicating an excess of iron in the body. Level of iron after the CT completion was higher in proBALL type cases((485.0 ± 22.7) ng/ml) compared to preBHLL ((278.3 ± 19.6) ng/ml) and «general» type ones ((311.1 ± 21.3) ng/ml)(р < 0.05). An inverse correlation was established between the ALL prognosis and SI (r = 1.0; р < 0.001) and SF levels (r = 0.44; р < 0.05). The average radiation dose to the BM was (3.87 ± 1.12) mSv with no effect on the type ofBM recovery during CT and iron metabolism. CONCLUSIONS: Proliferation and differentiation of hematopoietic elements during the BM recovery in ALL patientsunder CT depend on the iron metabolism. Excess iron in the body negatively affects the disease prognosis in children.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Comparison of Phenol Application and Endoscopic Pilonidal Sinus Treatment in Pediatric Pilonidal Sinus Disease. Pediatrics international : official journal of the Japan Pediatric Society 63.74 2 Unfinished Business and Experiences of Bereaved Families of Patients with Cancer: A Cross-Sectional Survey. Palliative medicine reports 61.0 3 The 21st International ``Ponte di Legno'' Childhood Acute Lymphoblastic Leukemia Workshop Report: Progress and Emerging Opportunities. Clinical lymphoma, myeloma & leukemia 49.0 4 Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type. Clinical lymphoma, myeloma & leukemia 64.12 5 Pediatric orbital solitary fibrous tumor/hemangiopericytoma presenting with isolated eyelid edema: a case report. Frontiers in pediatrics 53.1 6 Malignancies in patients with inborn errors of immunity: insights from 20-years of clinical experience in Qatar. Frontiers in immunology 68.6 7 Precision medicine and parental experience: a longitudinal study of psychosocial responses to germline genomic results in pediatric oncology. Frontiers in medicine 67.36 8 Cytokine-augmented risk stratification for six-month incident nephritis in children with IgA vasculitis. Frontiers in pediatrics 58.5 9 Time-bounded uncertainty in childhood cancer survivorship: a psycho-oncology perspective on result communication. Frontiers in psychology 57.0 10 "From misdiagnosis to precision medicine: strengthening pediatric neuro-oncology care in LMICs toward equitable pLGG outcomes". Frontiers in oncology 75.5 11 Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German-Austrian Expert Opinion Paper. European journal of neurology 66.4 12 Technical Considerations for Robotic Pediatric Lobectomy. Annals of thoracic surgery short reports 54.0 13 Kaposi Sarcoma-Associated Herpesvirus Is Not Detected in Osteosarcoma From KSHV-Endemic African Countries and the Non-Endemic United States Populations. Journal of medical virology 59.5 14 ELISA (Embedding-Linked Interactive Single-cell Agent): an interpretable hybrid generative Artificial Intelligence agent for expression-grounded discovery in single-cell genomics. Briefings in bioinformatics 48.5 15 Thyroid Cancer in the Modern Era: From Molecular Landscape and Multimodal Diagnostics to Integrative Traditional Chinese Medicine-A Comprehensive Review. Cancer management and research 90.6 16 Presumed left atrial myxoma presenting with seizures, massive stroke, and systemic embolization in an adolescent: a case report. International journal of emergency medicine 49.0 17 Ewing's Sarcoma in Adults: A Predictive Nomogram and Survival Analysis of a Cohort of 937 Patients. Journal of surgical oncology 73.92 18 Comments on "Initial Cerebrospinal Fluid Blast Clearance Rate in Pediatric B-Lymphoblastic Leukemia Is Associated With Overall Survival". Journal of pediatric hematology/oncology 49.12 19 Impact of Number of Lymph Nodes Sampled and Density of Positive Nodes on Outcomes Among Over 2000 Patients With Stage I to III Favorable Histology Wilms Tumor Enrolled on AREN03B2: A Children's Oncology Group Renal Tumor Study. Annals of surgery 70.5 20 Prognostic impact of risk organ involvement and metabolic parameters assessed by staging 18F-FDG PET/CT in pediatric Langerhans cell histiocytosis. Nuclear medicine communications 63.3 21 Prognostic value of plasma thymus- and activationregulated chemokine levels after the second cycle of chemotherapy in pediatric Hodgkin lymphoma. Haematologica 55.44 22 Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients. Haematologica 51.12 23 Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia". Haematologica 49.5 24 EARLY DISCONTINUATION OF ANTIBIOTICS IN PEDIATRIC PATIENTS WITH LOW- AND HIGH-RISK FEBRILE NEUTROPENIA: A SINGLE-CENTRE EXPERIENCE. Journal of the Pediatric Infectious Diseases Society 68.4 25 Comment on "How I Approach Anxiety in Children and Teens with Cancer". Pediatric blood & cancer 47.5 26 Progressive Tracheal Injury Following Tumor Regression in a Child With T-Cell Lymphoblastic Lymphoma. Pediatric blood & cancer 28.5 27 Very Late Relapse of Acute Myeloid Leukemia With a Rare HNRNPH1::MLLT10 Fusion Following a Pediatric Myeloid Neoplasm: A Successful Venetoclax-Azacitidine Bridge to Hematopoietic Stem Cell Transplantation. Pediatric blood & cancer 49.12 28 Interventions to Reduce Financial Toxicity of Childhood, Adolescent, and Young Adult Cancer Survivors: A Scoping Review. Pediatric blood & cancer 61.32 29 ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma. Pediatric blood & cancer 87.42 30 Advanced Radiotherapy Across a Multi-Geography Referral Network for Children With Ewing Sarcoma and Rhabdomyosarcoma: Treatment Delivery and Early Outcomes-A Single-Centre Experience. Pediatric blood & cancer 72.88 31 Genomic Characterization of ETV6::RUNX1-Positive Childhood B-ALL in a Chinese Cohort: Novel Fusion Partners, Co-Occurring Mutations, and Risk-Stratifying Biomarkers. Pediatric blood & cancer 59.75 32 Diagnostic Yield of Brain MRI in Pediatric Short Stature: Hypothalamic-Pituitary Lesions and Incidental Findings in Real-World Practice. Clinical endocrinology 67.3
PATIENT-FRIENDLY SUMMARY

THE PROLIFERATIVE-DIFFERENTIAL PROCESSES IN BONE MARROW UNDER CHEMOTHERAPY DELIVERY DEPENDING ON THE IRON METABOLISM IN CHILDREN WITH ACUTE LYMPHOID LEUKEMIA LIVING IN RADIOLOGICALLY CONTAMINATED TERRITORIES.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic